Author:
Pereira Hilka Flávia Barra do Espírito Santo Alves,Torres Kátia Luz,Fujimoto Luciana Botinelly Mendonça,Silva Felipe Luz Torres,Silva Thais Cristina Fonseca da,Melo Monica Maria Bandeira de,Silva Filho Agnaldo Lopes da
Abstract
Objective: The aim of the study was to identify the prevalence of human papillomavirus (HPV) infections using a self-collection device and also describe the frequency of P16INK4a overexpression in women deprived of liberty (WDL). Methods: This observational, cross-sectional, descriptive, analytical, and epidemiological study of the prevalence of HPV infection included 268 women deprived of liberty (WDL) in the state of Amazonas who performed self-collection using the Roche® HPV CTNG test. Patients with positive HPV results were submitted to a Pap smear in liquid medium, colposcopy, an immunocytochemistry evaluation using P16INK4a, and a biopsy, when necessary. Results: The age of the 268 women ranged from 19 to 64 years (mean±standard deviation: 33.5±9.1 years). HPV was detected in 66 (24.6%) women: 12 (4.5%) had HPV 16, 3 (1.1%) had HPV 18, 51 (19%) had other high-risk HPV genotypes, 21 (7.8%) had inconclusive results and 181 (67.5%) had negative results. Two women had a high-grade lesion and 13 had a low-grade lesion. Eight women showed alterations in their Pap smear and 32 (64%) presented overexpression of P16INK4a. Self-collection was well-accepted by 95.9% of the WDL. Conclusion: This study shows that the prevalence of HPV among the sample of WDL was high, that self-collection as a screening method was well-accepted and that the prison population has peculiar characteristics since there is a higher prevalence of other high-risk HPV genotypes.
Publisher
South Florida Publishing LLC
Reference30 articles.
1. Pan American Health Organization (PAHO) and World Health Organization (WHO). HPV and cervical cancer. World Health Organization; 2021.
2. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2023: incidência de câncer no Brasil [Internet]. 2022.https://www.gov.br/inca/ptbr/assuntos/cancer/numeros/estimativa/estado-capital/brasil. Accessed 19 Dec 2022.
3. World Health Organization. WHO Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization; 2021.
4. Oliveira AKDSG, Jacyntho CMA, Tso FK, Boldrini NAT, Speck NMG, Peixoto RAC, et al. HPV infection - screening, diagnosis and management of HPV-induced lesions. Rev Bras Ginecol Obstet 2021;43:240-6.
5. Sawaya GF, Smith-Mccune K, Kuppermann M. Cervical cancer screening: more choices in 2019. J Am Med Assoc 2019;321:2018-9.